H.B. Fuller Company confirmed receipt of an unsolicited proposal from Ancora Holdings Group to acquire its Building Adhesives Solutions (“BAS”) business for between $1.1 billion and $1.2 billion in cash.

Although Ancora previously expressed a passing verbal interest in BAS, the letter received today, simultaneous to the news being made public, represents the first offer that Ancora has made for this business.

Filtration Group Corporation adds to Parker’s portfolio of highly engineered products and leverages deep technical and application knowledge to serve key growth markets, including life sciences, HVAC/R, and in-plant and industrial. The company’s collection of established product brands are validated, specified and often sole-sourced. These capabilities complement Parker’s interconnected technology portfolio and increase its aftermarket presence, which the company expects will create strong recurring revenue streams across multiple product platforms.

Ford Motor Company announced it will return Lincoln production to the U.S. beginning in 2030. As part of this plan, Lincoln will phase out the importation of vehicles from China for the U.S. market, which will further strengthen Ford’s position as America’s No. 1 auto producer.

Fennell Tyres International, part of the Magna Tyres Group, is expanding into the South West of Western Australia with the acquisition of Bunbury’s Tyre Specialists. From Monday, 17 August, the Bunbury operation will officially become part of Fennell Tyres International, strengthening its presence and service capabilities across the region.

LANXESS is making its production at the Krefeld-Uerdingen site more sustainable. The specialty chemicals company will use hydrogen instead of natural gas to dry its iron oxide pigments. This will make the spray dryer one of the first large-scale industrial plants in Germany to use hydrogen as a fuel in continuous operation. LANXESS will thereby reduce its carbon footprint by about 6,000 metric tons per year.

Smithers announces that its Germany Medical Device Testing laboratory is formally accredited to the internationally recognized ISO/IEC 17025 standard for testing and calibration laboratories. This accreditation reaffirms the lab’s technical competence and commitment to delivering accurate, reliable data that supports product development and regulatory submissions for pharmaceutical and medical device manufacturers across Europe and globally.